Atlas Copco third quarter report 2013 (unaudited) Healthy

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Atlas Copco third quarter report 2013

(unaudited) Healthy profitability despite lower mining equipment revenues · Order intake decreased to MSEK 19 433 (21 379), organic decline of 6% · Revenues decreased to MSEK 20 552 (22 094), organic decline of 4% · Operating profit decreased by 14% to MSEK 4 212 (4 925) · Operating margin at 20.5% (22.3) · Profit before tax amounted to MSEK 4 017 (4 737) · Profit for the period was MSEK 3 054 (3 488) · Basic earnings per share were SEK 2.52 (2.87) · Operating cash flow at MSEK 2 404 (4 611, including divestment of customer financing assets of 1 400) · Actions to adjust capacity to lower mining equipment demand. Restructuring costs of MSEK 50 · Expanding into process vacuum solutions. Compressor Technique to acquire Edwards Group Ltd. Near term demand outlook The overall demand for the Group’s products and services is expected to remain at the current level. Previous near-term demand outlook (published July 17, 2013): The overall demand for the Group’s products and services is expected to remain at the current level. For further information please contact: Mattias Olsson, Vice President Investor Relations +46 (0)8 743 8295 or +46 (0)72 729 8295 ir@se.atlascopco.com Ola Kinnander, Media Relations Manager +46 (0)8 743 8060 or +46 (0)70 347 2455 media@se.atlascopco.com Atlas Copco discloses the information provided herein pursuant to the Securities Markets Act and/or the Financial Instruments Trading Act. Atlas Copco is an industrial group with world-leading positions in compressors, expanders and air treatment systems, construction and mining equipment, power tools and assembly systems. With innovative products and services, Atlas Copco delivers solutions for sustainable productivity. The company was founded in 1873, is based in Stockholm, Sweden, and has a global reach spanning more than 170 countries. In 2012, Atlas Copco had 39 800 employees and revenues of BSEK 90.5 (BEUR 10.5). Learn more at www.atlascopco.com.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Scorpius Holdings Boosts Efficiency with New Cost Reduction Plan

Updated Category News Views 183

Scorpius Holdings Implements Significant Cost-Saving Strategies Scorpius Holdings, Inc. (NYSE American: SCPX), a notable player in the biomanufacturing landscape, has recently introduced a series of strategic cost-saving measures. These initiatives aim to reduce operational costs by more than $2 million annually, showcasing the company's commitment to enhancing its...

Continue Reading
McKesson's Strategic Shift: Selling Rexall and Well.ca

Updated Category News Views 122

McKesson Corporation Expands Focus on Healthcare Services IRVING, Texas - McKesson Corporation (NYSE: MCK), a leader in healthcare services with a market capitalization of $72.45 billion and annual revenue exceeding $330 billion, has officially completed the sale of its Rexall and Well.ca businesses to Birch Hill Equity Partners. This noteworthy decision allows McKesson...

Continue Reading
GSI Group Enhances Market with GenesisBPS Acquisition

Updated Category News Views 155

GSI Group Strengthens Its Portfolio GSI Group Holdings has made a significant move by acquiring GenesisBPS, an innovative designer and manufacturer of specialized benchtop blood processing equipment and laboratory consumables. This acquisition enhances GSI Group's expanding global sales platform, reinforcing its commitment to serving the life sciences, research and...

Continue Reading
Forecasting Growth in the Antidepressant Drugs Market

Updated Category News Views 156

Understanding the Antidepressant Drugs Market The Antidepressant Drugs Market is anticipated to undergo significant growth, with a projection to reach USD 26.9 billion by 2033. This upward trend reflects a compound annual growth rate (CAGR) of 3.3% from 2024 to 2033, highlighting the increasing reliance on these medications to treat depression. Antidepressants are...

Continue Reading
Inceptio Technology Introduces Strategic Vision for L4 Trucks

Updated Category News Views 227

A Visionary Approach to L4 Autonomous Trucking by Inceptio Technology Inceptio Technology is making significant strides in the field of autonomous trucking, sharing its detailed strategy for scaling Level 4 (L4) autonomous trucks. The company recently took center stage at the Next Truck 2025 conference, demonstrating its commitment to reshaping the future of...

Continue Reading